Plug-and-Play Lab on Chip Systems

Boston-based Emulate earlier this year raised $28 Million to commercialize its organs-on-chips technology. The goal is to create a lab-ready system to could aid in everything from drug development to consumer product design. Emulate's automated system includes organ chips, instrumentation, and software apps, the company says. Emulate, a spin-off from Harvard University's Wyss Institute, has said the plug-and-play system will "allow end users to easily conduct experiments within their own labs, without requiring specialized expertise."

Read the full Qmed story.

7 IVD Breakthroughs You Need to Know>>

[Image courtesy of Emulate]